424B4424B4
Jun 9, 2026Final prospectus0001193125-26-263914
All companies
Trade Eloxx Pharmaceuticals Inc424B4Jun 9, 2026
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
EL
Eloxx Pharmaceuticals Inc
ELOXPublic
PublicUnited States(NASDAQ Capital)Since IPO +26.27%1 market
Public listing
Listed· NASDAQ Capital· Listing market: United StatesListing date
Jun 9, 2026
Final IPO price
$11.00
Shares offered
2,975,000
Offering proceeds
$32.73M
Sources: sec-edgar, sec-harvest, nasdaq
IPO Calendar · NASDAQIPO
ELOXPrice
$13.89
24h
-0.64%
Valuation
—
24h volume
$199.36K
Type
IPO
Trade Eloxx Pharmaceuticals IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 2h ago
Eloxx Pharmaceuticals Inc IPO public float & lock-up
Public float and locked shares extracted from Eloxx Pharmaceuticals Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Total shares (FD)
4.04M
Public float
2.98M
Locked
1.06M
IPO raise
—
Next unlock
—
Needs review: Could not extract a detailed lock-up release schedule.
Financials
UnprofitableFrom SEC filings, latest FY ending Dec 31, 2025 · CIK 0001035354.
Revenue · -100.00% YoY
$0
Net income
-$6M
Gross margin
—
Cash
$4.79M
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $6.36M | $0 | — | — |
| Operating income | -$6.44M | -$2.47M | -$17.29M | -$34.42M | -$66.02M |
| Net income | -$6M | -$3.14M | -$17.05M | -$36.07M | -$66.73M |
| R&D expense | — | — | — | — | — |
| Cash & equivalents | $4.79M | $111K | $1.13M | $19.21M | $42.27M |
| Total assets | $5.27M | $2.98M | $1.71M | $21.12M | $45.14M |
| Total liabilities | $17.18M | $27.31M | $24.31M | $31.78M | $22.76M |
| Shareholders' equity | -$11.91M | -$24.34M | -$22.6M | -$10.66M | $22.38M |
About Eloxx Pharmaceuticals Inc
Eloxx Pharmaceuticals Inc is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.
What the company does
- Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
- Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
- Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.
Business profile
Eloxx Pharmaceuticals Inc belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.
SEC IPO filings
Final prospectusEDGAR filings resolved from ELOX / CIK 0001035354.
Jun 8, 2026Effective9999999995-26-001918
Jun 8, 2026Exchange registration0001354457-26-000547
S-1/AS-1/A
Jun 4, 2026Amended0001193125-26-257750
8-A12B8-A12B
Jun 1, 2026Exchange registration0001193125-26-251780
S-1/AS-1/A
Jun 1, 2026Amended0001193125-26-251655
S-1S-1
May 7, 2026Filed0001193125-26-212324
Mar 20, 2026Confidential draft0001193125-26-116406
Aug 30, 2021Effective9999999995-21-003359
CORRESPfilename1.htm
Aug 26, 2021SEC correspondence0001104659-21-109793
UPLOADfilename1.pdf
Aug 26, 2021SEC correspondence0000000000-21-010428
Nov 26, 2018Effective9999999995-18-002971
Latest Eloxx Pharmaceuticals Inc IPO news
Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.
PR NewswireJun 8, 2026IPO filing
PR Newswire published Eloxx Pharmaceuticals’ announcement that it priced its $66.0 million public offering and its uplisting to the Nasdaq Capital Market; it also notes trading under Nasdaq symbol ELOX expected to begin June 9, 2026.
Eloxx Pharmaceuticals Inc IPO — frequently asked questions
- When did Eloxx Pharmaceuticals Inc go public?
- Eloxx Pharmaceuticals Inc completed its IPO on Jun 9, 2026 on NASDAQ Capital under the ticker ELOX and now trades publicly.
- What was Eloxx Pharmaceuticals Inc's IPO price?
- Eloxx Pharmaceuticals Inc priced its IPO at $11.00 per share.
- Can I buy Eloxx Pharmaceuticals Inc stock?
- Yes — Eloxx Pharmaceuticals Inc is publicly traded on NASDAQ Capital as ELOX. You can follow its live price, valuation and post-IPO performance above.